Ricardo Rodriguez Perales, MD
Dermatology · Guaynabo, PRNPI 1306834098
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,188 of the $7,362 with a category attached, or 70.5%. 11 manufacturers reported payments, led by AbbVie at 34.6% of the total. Reporting peaked in 2022 at $2,625 and has fallen 58.8% since, to $1,081 in 2025.
Across 176 payments — averaging $41.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- E.r. Squibb & Sons, L.L.C.$2K
- Johnson & Johnson$849
- Sanofi$439
- PBG Puerto Rico LLC$388
- Eli Lilly Export S.A. Puerto Rico Branch$262
- plus $430 from 5 others
What the payments were for
- Consulting fees$1,65022%
- Food & beverage$5,18870%
- Education$5247%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $2,545 |
| E.r. Squibb & Sons, L.L.C. | 14 | $2,450 |
| Johnson & Johnson(2 entities) | 16 | $849 |
| Sanofi | 17 | $439 |
| PBG Puerto Rico LLC | 18 | $388 |
| Eli Lilly Export S.A. Puerto Rico Branch | 12 | $262 |
| Amgen | 9 | $245 |
| Novartis | 4 | $73 |
| Pfizer | 2 | $50 |
| Sanofi-aventis U.S. LLC | 1 | $35 |
| Galderma Laboratories, L.p. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,362 in reported general payments places this provider in the 85th percentile of 108 dermatology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 13 | $1,130 |
| Betamethasone Valerate | 26 | $1,130 |
| Clobetasol Propionate | 19 | $1,013 |
| Ciclopirox | 14 | $694 |
| Desonide | 29 | $618 |
| Ketoconazole | 26 | $536 |
| Triamcinolone Acetonide | 16 | $301 |
| Minoxidil | 13 | $222 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Guaynabo
- Rocio Mandry PaganGuaynabo$5K
- Fabiola PabonGuaynabo$3K
- Carla Cruz-DiazGuaynabo$2K
- Gabriela Pabon CartagenaGuaynabo$2K
- Jose Gonzalez ChavezSan Juan$248K
- Rafael Martin GarciaSan Juan$199K
- Noelani Gonzalez-OrtizSan Juan$154K
- Alma Cruz SantanaCarolina$74K
- Eneida de la TorreBayamon$39K
- Samuel SanchezCaguas$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.